QC
PRME icon

Quadrature Capital’s Prime Medicine PRME Stock Holding History

Quadrature Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Sell
46,893
-5,973
-11% -$22.7K ﹤0.01% 1159
2025
Q4 		$183K Buy
52,866
+42,684
+419% +$190K ﹤0.01% 994
2025
Q3 		$56.3K Buy
+10,182
New +$41.4K ﹤0.01% 946
2025
Q2 		– Sell
-24,802
Closed -$49.6K – 1391
2025
Q1 		$49.6K Buy
+24,802
New +$63.3K ﹤0.01% 977

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Quadrature Capital's PRME Position: Q1 2026 in Review

Quadrature Capital reduced its Prime Medicine (PRME) stake by 11% in Q1 2026, selling an estimated $22.7K and leaving 46,893 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Quadrature Capital first reported a position in PRME in Q1 2025 and has held it in 4 quarters since. The position peaked at $183K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Quadrature Capital held 46,893 shares of Prime Medicine worth $163K as of Q1 2026.
  • Quadrature Capital sold 5,973 Prime Medicine shares in Q1 2026, an estimated $22.7K.
  • Prime Medicine made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1159 holding.
  • Quadrature Capital first reported a position in Prime Medicine in Q1 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Prime Medicine position peaked at $183K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.